Howard County BOE sues drug manufacturers over surging insulin prices - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Health/Employee Benefits News
Newswires RSS Get our newsletter
Order Prints
July 1, 2025 Newswires
Share
Share
Post
Email

Howard County BOE sues drug manufacturers over surging insulin prices

April Santana, Baltimore SunBaltimore Sun

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, UnitedHealth Group and several other drug manufacturers accusing the companies of deliberately inflating insulin prices for profit.

The school board is responsible for purchasing insurance for all of its employees, retirees and dependents. The district has more than 7,800 educators, administrators and staff, according to the complaint.

Increases in spending have “detrimental effects” on the budget and consequently, the school board’s ability to provide services to the community, the lawsuit states.

During the past 20 years, the average cost of consumer goods and services has risen 1.75-fold while the cost of some diabetes medications has risen more than 10-fold, the complaint reads. The price increases are not caused by a rise in production costs or investments in development but by the defendants manipulating them to “exponentially increase their profits at the expense of payors.” This is all part of what the suit calls an “Insulin Pricing Scheme” by insulin manufacturers.

Health insurance plans are funded by payors such as Howard County Board of Education. They provide coverage and reimbursements for medical treatment and care.

Pharmacy benefits managers CVS Caremark, Express Scripts and OptumRx, named in the suit, are responsible for establishing national formularies — a list of approved drugs — and determining which diabetes medications are covered.

The defendants are the largest benefits managers in the country, owning more than 80% of the market, the lawsuit states. They are also the largest pharmacies in the U.S. and are owned and controlled by entities that own three of the largest insurance companies in the U.S.

The national formularies drive drug utilization, the suit states, and the exclusion of a drug from one or more of the benefit managers’ formularies can render the drug virtually inaccessible for millions.

The complaint argues manufacturers are artificially inflating their list prices and then paying a significant, yet undisclosed, portion of that inflated price back to the PBMs through rebate aggregators. The aggregators are PBM subsidiaries and “secure additional profits from each drug purchase.”

“The PBMs intentionally work to incentivize the Manufacturers to inflate their list prices,” the complaint said. “The PBMs’ ‘negotiations’ intentionally drive up the price of the at-issue drugs and are directly responsible for the skyrocketing prices of diabetes medications, conferring unearned benefits upon the PBMs and Manufacturers alike and overcharging payors like Howard County BOE. ”

Payors like the Howard County Board of Education have been overcharged millions because of this, the suit alleges. Earlier this year, Baltimore City Board of School Commissioners filed a similar suit.

Pharmaceutical companies alone are responsible for the prices they set in the marketplace for the products they manufacture, Monica Prinzing, a CVS spokesperson, said in a statement.

“Nothing in our agreements prevents drug manufacturers from lowering the prices of their insulin products and we would welcome such an action,” Prinzing said. ” Allegations that we play any role in determining the prices charged by manufacturers for their products are false, and we intend to vigorously defend against this baseless suit.”

Optum Rx said the lawsuit is baseless, demonstrating a “profound misunderstanding of how drug pricing works.”

“For many years, Optum Rx has aggressively and successfully negotiated with drug manufacturers and taken additional actions to lower prescription insulin costs for our health plan customers and their members, who now pay an average of less than $18 per month for insulin,” Isaac Sorensen, an Optum spokesperson said in a statement. “PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices. ”

Eli Lilly, Novo Nordisk, UnitedHealth Group, and Sanofi-Aventis did not immediately respond to requests for comment.

Have a news tip? Contact April Santana at asantana@baltsun.com or at 443-834-7525.

©2025 Baltimore Sun. Visit baltimoresun.com. Distributed by Tribune Content Agency, LLC.

Older

Trump shares handwritten note to Powell: 'You have cost the USA A Fortune'

Newer

How Trump's tax bill could cut Medicaid for millions of Americans

Advisor News

  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
  • Semi-retirement: helping clients balance flexibility with financial security
More Advisor News

Annuity News

  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Global Atlantic launches ForeIncome Flex
  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
More Annuity News

Health/Employee Benefits News

  • MEDICAL FRAILTY AND MEDICAID WORK REQUIREMENTS: CHALLENGES FOR PEOPLE WITH MENTAL HEALTH CONDITIONS
  • HOW NEW PHYSICIANS CAN AVOID PAYMENT PITFALLS IN MEDICARE AND MEDICAID
  • WHITEHOUSE, WYDEN, OSSOFF DEMAND BIG HEALTH INSURANCE CEOS DELIVER ON PROMISES TO REDUCE PATIENT CARE DELAYS
  • Medicaid work rules don’t apply to Native Americans. They could still lose coverage.
  • Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
More Health/Employee Benefits News

Life Insurance News

  • Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
  • Military Briefs: November 19-25
  • California’s new solvency rules: What should life insurance advisors watch?
  • Navigating delayed death certificates: A guide for life insurance advisors
  • Jackson Launches Direct-to-Consumer Annuity Offering
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.